Role of IL-17 and IL-22 in autoimmunity and cancer
Papel de la IL-17 e IL-22 en autoinmunidad y cáncer
Leído
5076
Vecesse ha leído el artículo
2975
Total PDF
2101
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 58 | 106 | 164 |
| 2025 5 | 59 | 62 | 121 |
| 2025 4 | 47 | 43 | 90 |
| 2025 3 | 48 | 28 | 76 |
| 2025 2 | 55 | 32 | 87 |
| 2025 1 | 41 | 32 | 73 |
| 2024 12 | 57 | 34 | 91 |
| 2024 11 | 43 | 65 | 108 |
| 2024 10 | 43 | 66 | 109 |
| 2024 9 | 35 | 40 | 75 |
| 2024 8 | 48 | 78 | 126 |
| 2024 7 | 34 | 50 | 84 |
| 2024 6 | 50 | 24 | 74 |
| 2024 5 | 31 | 45 | 76 |
| 2024 4 | 58 | 40 | 98 |
| 2024 3 | 37 | 34 | 71 |
| 2024 2 | 31 | 51 | 82 |
| 2024 1 | 22 | 42 | 64 |
| 2023 12 | 17 | 16 | 33 |
| 2023 11 | 29 | 50 | 79 |
| 2023 10 | 15 | 28 | 43 |
| 2023 9 | 26 | 37 | 63 |
| 2023 8 | 14 | 25 | 39 |
| 2023 7 | 27 | 32 | 59 |
| 2023 6 | 25 | 29 | 54 |
| 2023 5 | 24 | 20 | 44 |
| 2023 4 | 22 | 27 | 49 |
| 2023 3 | 31 | 34 | 65 |
| 2023 2 | 17 | 17 | 34 |
| 2022 1 | 17 | 38 | 55 |
| 2022 12 | 22 | 37 | 59 |
| 2022 11 | 17 | 20 | 37 |
| 2022 10 | 17 | 13 | 30 |
| 2022 9 | 18 | 33 | 51 |
| 2022 8 | 19 | 35 | 54 |
| 2022 7 | 20 | 29 | 49 |
| 2022 6 | 21 | 17 | 38 |
| 2022 5 | 17 | 37 | 54 |
| 2022 4 | 31 | 25 | 56 |
| 2022 3 | 38 | 66 | 104 |
| 2022 2 | 21 | 19 | 40 |
| 2021 1 | 26 | 45 | 71 |
| 2021 12 | 30 | 53 | 83 |
| 2021 11 | 28 | 41 | 69 |
| 2021 10 | 38 | 43 | 81 |
| 2021 9 | 20 | 57 | 77 |
| 2021 8 | 21 | 34 | 55 |
| 2021 7 | 23 | 49 | 72 |
| 2021 6 | 32 | 41 | 73 |
| 2021 5 | 30 | 43 | 73 |
| 2021 4 | 52 | 79 | 131 |
| 2021 3 | 34 | 37 | 71 |
| 2021 2 | 17 | 34 | 51 |
| 2020 1 | 23 | 25 | 48 |
| 2020 12 | 23 | 22 | 45 |
| 2020 11 | 16 | 34 | 50 |
| 2020 10 | 14 | 16 | 30 |
| 2020 9 | 17 | 14 | 31 |
| 2020 8 | 15 | 25 | 40 |
| 2020 7 | 24 | 22 | 46 |
| 2020 6 | 29 | 22 | 51 |
| 2020 5 | 19 | 24 | 43 |
| 2020 4 | 18 | 18 | 36 |
| 2020 3 | 21 | 18 | 39 |
| 2019 5 | 0 | 0 | 0 |
| 2018 3 | 3 | 4 | 7 |
| 2018 2 | 11 | 36 | 47 |
| 2018 1 | 12 | 23 | 35 |
| 2017 12 | 10 | 25 | 35 |
| 2017 11 | 10 | 24 | 34 |
| 2017 10 | 5 | 25 | 30 |
| 2017 9 | 5 | 27 | 32 |
| 2017 8 | 12 | 19 | 31 |
| 2017 7 | 7 | 36 | 43 |
| 2017 6 | 16 | 27 | 43 |
| 2017 5 | 19 | 37 | 56 |
| 2017 4 | 17 | 35 | 52 |
| 2017 3 | 14 | 51 | 65 |
| 2017 2 | 8 | 20 | 28 |
| 2016 1 | 9 | 36 | 45 |
| 2016 12 | 14 | 34 | 48 |
| 2016 11 | 24 | 18 | 42 |
| 2016 10 | 24 | 26 | 50 |
| 2016 9 | 1 | 1 | 2 |
| 2016 7 | 2 | 5 | 7 |
| 2016 5 | 0 | 4 | 4 |
| 2016 4 | 0 | 11 | 11 |
| 2016 2 | 0 | 14 | 14 |
| 2015 1 | 0 | 7 | 7 |
| 2015 12 | 0 | 4 | 4 |
| 2015 11 | 0 | 9 | 9 |
| 2015 10 | 0 | 5 | 5 |
| 2015 9 | 0 | 12 | 12 |
| 2015 7 | 0 | 1 | 1 |
| 2015 6 | 0 | 11 | 11 |
| 2015 5 | 0 | 4 | 4 |
| 2015 4 | 0 | 13 | 13 |
| 2015 3 | 0 | 15 | 15 |
| 2015 2 | 3 | 4 | 7 |
| 2015 1 | 1 | 0 | 1 |
| 2014 12 | 1 | 0 | 1 |
| 2014 11 | 1 | 0 | 1 |
Mostrar todo
